Total Funding
19
25
Total FundingSeries C raised
Growth Score
-5 pts
Heat Score
17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
19991
Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.
- Zhi Hong: Co-Founder and CEOPast Role: GSK, Senior Vice President and Head
- Jim Klein: Chief Financial Officer
About the Company
Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese
healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.
